Dr. Yitzhak D. Haim, MD

Dr. Haim practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Haim's NPI, 1831178698, was assigned on January 11, 2006. Dr. Haim graduated from Tel Aviv University Sackler in 1985. Dr. Haim holds Florida license ME69117.

Dr. Haim's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Haim's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Haim is also affiliated with AdventHealth DeLand. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Haim to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haim practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Haim's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Haim is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Haim's licenses on file in 4 states: Florida, Alabama, New York and Pennsylvania.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), hypersomnia, lung resection, pleural effusion and pneumonia among the conditions Dr. Haim treats.

CMS data shows 5,339 Medicare services from Dr. Haim across 23 procedure codes in 2024, for 1,398 Medicare patients. Medicare paid $445,540 for them.

CMS counts 1,398 Medicare patients who saw Dr. Haim in 2024. The largest group is 75 to 84, with 580 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Haim's median patient age at 72, with 50% women.

In 2024, Dr. Haim wrote 1,915 Medicare Part D claims for 438 patients. 48% of them were for generic drugs. CMS names the drug for 1,726 of them, across 33 drugs with 11 or more claims each, at $969,966 in total drug cost. In 2023, CMS named 1,543 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Haim for performance year 2024, reported as part of a group. Dr. Haim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Haim as offering telehealth.

Dmand AI links 1 paper to Dr. Haim in 2019. Dr. Haim's most frequent co-author is Barry S. Weinstock, MD.

CMS Open Payments shows 510 general payments to Dr. Haim from 57 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 48% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $23,378.

Dmand AI lists 2 awards for Dr. Haim, most recently Checkbook Top Doc in 2012.

Dr. Haim graduated from Tel Aviv University Sackler in 1985.

Dr. Haim is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.